Johnson & Johnson stock after-hours at EUR 227.63: minus 1.39 percent versus prior close
Published on 10/02/2026 at 18:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson stock was at EUR 227.63 in after-hours trading at 6:46 p.m. CEST on October 2, 2026, according to Lang & Schwarz. The price was down EUR 3.20, or 1.39 percent, versus the prior Lang & Schwarz close of EUR 230.83.
Trading after the Xetra close
Lang & Schwarz recorded a bid of EUR 227.60 and an ask of EUR 227.65 for Johnson & Johnson shares. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.
Johnson & Johnson reports two-year ICOTYDE data
In a company release dated October 2, 2026, Johnson & Johnson announced new two-year results from the Phase 3 ICONIC-TOTAL study of ICOTYDE, or icotrokinra, in adults and adolescents with plaque psoriasis affecting high-impact sites. The data were presented at the 2026 European Academy of Dermatology and Venereology Congress.
Through Week 112, 70 percent of ICOTYDE-treated patients achieved clear or almost clear skin under the study’s Investigator’s Global Assessment measure. Site-specific complete clearance at Week 112 was reported for 60 percent of patients with scalp psoriasis and 89 percent of those with genital psoriasis. Johnson & Johnson said safety findings through Week 112 remained consistent with the established safety profile.
